Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Post by Hideawayon Dec 21, 2021 7:49am

Another NR

IMV Announces Finalization of the Basket Clinical Study in Collaboration with Merck and Reveals Promising Top Line Data from the Bladder and MSI-High Cohorts  Download as PDF DECEMBER 21 ...more  
206
Discussion
Post by Betteryear2on Dec 21, 2021 7:49am

Finalization of the Basket Clinical Study

December 21, 2021 07:05 AM Eastern Standard Time DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio ...more  
118
Comment by gardyon Dec 20, 2021 4:46pm

RE:RE:NR

Ten more years of cheap warrants for 2 years of runway. Not impressed unless of course we start seeing positive results in the not too distant future.  Gardy
102
Discussion
Comment by zalmonellaon Dec 20, 2021 3:26pm

RE:NR

Well, that looks like about 1 year burn, added to their other cash should give them up to 2 years to produce results. It looks like it's tied to producing results, so everybody must be pretty sure ...more  
160
Discussion
Post by Hideawayon Dec 20, 2021 9:13am

NR

IMV Strengthens its Financial Position with the Completion of a US$25 Million Long-Term Debt Facility  Download as PDF DECEMBER 20, 2021 7:05AM EST   This facility supports the ...more  
211
Discussion
Post by antigua1987on Dec 13, 2021 3:52pm

Along the lines of giving credit where it's due or not,

...M Jasmin, who has delivered many o' tossed salad at SH readers, was hired as IR senior director in Dec/18, when SP was CAD7$+ and oncology investor optimism was near all time peak (covid head ...more  
328
Comment by Hideawayon Dec 10, 2021 12:19pm

RE:ESMO Conference Poster Presentation Conclusions

These results do not appear to be spectacular but my scientific knowledge is limited and considering the difficulty in treating this particular cancer perhaps the conclusions are not all that bad ...more  
243
Discussion
Post by Hideawayon Dec 10, 2021 12:14pm

ESMO Conference Poster Presentation Conclusions

Conclusion • Increases in both T and B cell immune infiltration in tumors are associated with >10% tumor reduction in patients treated with MVP-S based therapy, • Natural antibodies against ...more  
239
Discussion
Comment by gardyon Dec 07, 2021 1:13pm

RE:RE:RE:RE:RE:RE:RE:NR

Mansour did a way better job then Fred did. Ors was a disaster. The longer this takes the less relavent their proprieatry property becomes with so many other companies out there with different ideas ...more  
228
Discussion
Comment by prosciuttoon Dec 06, 2021 3:39pm

RE:RE:RE:RE:RE:RE:NR

They need to be very cautious about a new CEO. I think thats where they f'ed up most over the last 10 years. A scientist can NOT be a CEO. Taking a 2 year MBA on top of decades of science doesnt ...more  
183
Discussion
Comment by alphaseeking001on Dec 06, 2021 3:16pm

RE:RE:RE:RE:RE:NR

I absolutely don't have any idea where this company really is right now.  It's frustrating in the extreme.  On the one hand, their tech seems good (has seemed so for 10 y with so far ...more  
170
Discussion
Comment by Jthom376on Dec 06, 2021 11:02am

RE:RE:RE:RE:NR

It's a strange company... 70 employees, have not hit one milestone for the two years I've been here. Anything they announce this year would've been what they planned on announcing in Q1 ...more  
166
Discussion
Comment by gardyon Dec 04, 2021 8:14pm

RE:RE:RE:NR

I guess some people here did not like what had to say. Too bad,I guess the truth hurts.  Gardy
114
Discussion
Comment by gardyon Dec 03, 2021 11:26am

RE:RE:NR

Because all of this is taking to long. I met with the old regime over 10 years ago and ovarian cancer was at the top of the list. here we are over 10 years later and were still in phase 2. Biggest ...more  
238
Discussion
Comment by Hideawayon Dec 02, 2021 11:03am

RE:NR

These results seem very good but don't appear to impress the market much. Comments from some of the more experienced posters would be appreciated and helpful.
127
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities